Download PDF
1 / Pages

Other users also viewed these articles

Effectiveness and safety of rituximab in systemic lupus erythematosus: A case series describing the experience of 2 centres Vicenç Juan Gómez; Irene Carrión-Barberá; Tarek Carlos Salman Monte; Asunción Acosta; Vicenç Torrente-Segarra; Jordi Monfort;
Reumatol Clin. 2020;16P2:391-5
Follow-up of clinical activity and accumulated organic damage in a cohort of patients with systemic lupus erythematosus from the Yucatán Peninsula, Mexico (1995¿2016) Ricardo F. López-Villanueva; Guillermo Valencia-Pacheco; Rita Zapata-Vázquez; Ricardo López-Suárez; Carlos Castro-Sansores;
Reumatol Clin. 2023;19:106-13
Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology Ana Urruticoechea-Arana; Fernando León-Vázquez; Vicente Giner-Ruiz; José Luis Andréu-Sánchez; Alejandro Olivé-Marqués; Mercedes Freire-González; José María Pego-Reigosa; Santiago Muñoz-Fernández; José A. Román-Ivorra; Juan José Alegre-Sancho; Francisco Vargas-Negrín; María Medina-Abellán; Tatiana Cobo-Ibáñez; Xavier Mas-Garriga; Jaime Calvo-Alén; Carmen Costa-Ribas; Ricardo Blanco-Vela; Álvaro Pérez-Martín; Emma Beltrán-Catalán; Jordi Forcada-Gisbert; María Victoria Hernández-Miguel; Juan Carlos Hermosa-Hernán; Javier Narváez-García; Enrique Nieto-Pol; Íñigo Rúa-Figueroa;
Reumatol Clin. 2020;16P2:373-7